Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.87% |
| 2 | Technology | 11.53% |
| 3 | Consumer Discretionary | 11.36% |
| 4 | Healthcare | 11.05% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFSI
2976
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $622K | ﹤0.01% |
61,796
| – | – |
|
|
GNCMA
2977
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $622K | ﹤0.01% |
15,932
-4,459
| -22% | -$182K |
|
2978
Nomura Holdings
NMR
$28.4B
| $621K | ﹤0.01% |
106,673
+58,473
| +121% | +$339K |
|
|
INFN
2979
DELISTED
Infinera Corporation Common Stock
INFN
| $621K | ﹤0.01% |
+98,077
| New | +$747K |
|
|
LRFC
2980
DELISTED
Logan Ridge Finance Corp
LRFC
| $620K | ﹤0.01% |
14,191
-2,652
| -16% | -$129K |
|
2981
Winmark
WINA
$1.22B
| $620K | ﹤0.01% |
+4,795
| New | +$634K |
|
2982
CVB Financial
CVBF
$3.98B
| $618K | ﹤0.01% |
26,222
+3,852
| +17% | +$91.5K |
|
|
UBA
2983
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $618K | ﹤0.01% |
28,405
-86,255
| -75% | -$1.93M |
|
2984
Malibu Boats
MBUU
$557M
| $617K | ﹤0.01% |
20,743
-154,003
| -88% | -$4.7M |
|
|
BETR
2985
DELISTED
Amplify Snack Brands, Inc.
BETR
| $617K | ﹤0.01% |
+51,408
| New | +$370K |
|
2986
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$222M
| $616K | ﹤0.01% |
+25,632
| New | +$590K |
|
2987
Savara
SVRA
$1.13B
| $615K | ﹤0.01% |
41,441
-259,215
| -86% | -$2.97M |
|
2988
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
| $614K | ﹤0.01% |
10,112
+6,472
| +178% | +$385K |
|
2989
Corvus Pharmaceuticals
CRVS
$1.11B
| $611K | ﹤0.01% |
59,017
+37,998
| +181% | +$487K |
|
2990
NN Inc
NNBR
$271M
| $610K | ﹤0.01% |
+22,086
| New | +$627K |
|
2991
PUT
Exelixis
EXEL
$14B
| $608K | ﹤0.01% |
20,000
-4,300
| -18% | -$114K |
|
|
DO
2992
DELISTED
Diamond Offshore Drilling
DO
| $607K | ﹤0.01% |
32,672
-655,039
| -95% | -$10.7M |
|
2993
PhenixFIN
PFX
$84.1M
| $606K | ﹤0.01% |
5,805
-360
| -6% | -$41.1K |
|
|
CBAY
2994
DELISTED
Cymabay Therapeutics
CBAY
| $604K | ﹤0.01% |
65,681
-1,637,443
| -96% | -$14M |
|
|
DRNA
2995
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $604K | ﹤0.01% |
66,907
+39,348
| +143% | +$289K |
|
2996
Sinclair Inc
SBGI
$1B
| $600K | ﹤0.01% |
+15,852
| New | +$525K |
|
|
DOC
2997
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $600K | ﹤0.01% |
33,360
-426,755
| -93% | -$7.65M |
|
|
CATC
2998
DELISTED
CAMBRIDGE BANCORP
CATC
| $598K | ﹤0.01% |
+7,499
| New | +$566K |
|
2999
Sabesp
SBS
$19.7B
| $597K | ﹤0.01% |
294,520
-2,192,821
| -88% | -$4.21M |
|
3000
Charles River Laboratories
CRL
$10.8B
| $595K | ﹤0.01% |
5,433
-216,504
| -98% | -$23.6M |
|
Similar funds
Millennium Management's Q4 2017 Portfolio in Review
As of Q4 2017, Millennium Management held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Millennium Management's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Millennium Management's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Millennium Management fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Millennium Management's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Millennium Management opened 897 new positions and closed 601 in Q4 2017.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.